المؤلفون: Rocha KML; Department of Pharmacy, Faculty of Health Sciences, University of Brasília, Brasília 70910-900, DF, Brazil., Nascimento ÉCM; Department of Pharmacy, Faculty of Health Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.; Computational Chemistry Laboratory, Institute of Chemistry, University of Brasília, Brasília 70910-900, DF, Brazil., de Jesus RCC; Department of Pharmacy, Faculty of Health Sciences, University of Brasília, Brasília 70910-900, DF, Brazil., Martins JBL; Department of Pharmacy, Faculty of Health Sciences, University of Brasília, Brasília 70910-900, DF, Brazil.; Computational Chemistry Laboratory, Institute of Chemistry, University of Brasília, Brasília 70910-900, DF, Brazil.

المصدر: Molecules (Basel, Switzerland) [Molecules] 2024 Sep 08; Vol. 29 (17). Date of Electronic Publication: 2024 Sep 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE

مواضيع طبية MeSH: Fusion Proteins, bcr-abl*/antagonists & inhibitors , Fusion Proteins, bcr-abl*/genetics , Fusion Proteins, bcr-abl*/chemistry , Afatinib*/chemistry , Afatinib*/pharmacology , Protein Kinase Inhibitors*/chemistry , Protein Kinase Inhibitors*/pharmacology , Molecular Docking Simulation*, Humans ; Models, Molecular ; Computer Simulation ; Mutation ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Hydrogen Bonding ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Imidazoles/chemistry ; Imidazoles/pharmacology ; Pyridazines

المؤلفون: Abdallah AM; Department of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE 57357), Cairo, Egypt., Hafez H; Department of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE 57357), Cairo, Egypt.; Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt., Madney Y; Department of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE 57357), Cairo, Egypt.; Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt., Ahmed S; Department of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE 57357), Cairo, Egypt.; Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt., Yassin D; Department of Clinical Pathology, Children's Cancer Hospital Egypt (CCHE 57357), Cairo, Egypt.; Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt., Salem S; Department of Clinical Pathology, Children's Cancer Hospital Egypt (CCHE 57357), Cairo, Egypt.; Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt., Yousry R; Department of Research, Children's Cancer Hospital (CCHE 57357), Cairo, Egypt., Abdel-Azim H; Cancer Center, Children Hospital and Medical Center, Loma Linda University, Loma Linda, CA, USA., Lehmann L; Pediatric Stem Cell Transplantation Unit, Dana Farber Cancer Institute, Boston, MA, USA., Elhaddad A; Department of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE 57357), Cairo, Egypt.; Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Jul; Vol. 65 (7), pp. 1024-1027. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Letter

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/diagnosis , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/adverse effects, Humans ; Child ; Adolescent ; Treatment Outcome ; Female ; Prognosis ; Male ; Child, Preschool ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/antagonists & inhibitors ; Tyrosine Kinase Inhibitors

المؤلفون: Abruzzese E; From the Department of Hematology, S. Eugenio Hospital, Tor Vergata University, Azienda Sanitaria Locale Roma 2, Rome.

المصدر: The New England journal of medicine [N Engl J Med] 2024 Sep 12; Vol. 391 (10), pp. 955-957.

نوع المنشور: Editorial; Historical Article

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/administration & dosage , Antineoplastic Agents*/adverse effects , Antineoplastic Agents*/history , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/history , Tyrosine Kinase Inhibitors*/administration & dosage , Tyrosine Kinase Inhibitors*/adverse effects , Tyrosine Kinase Inhibitors*/history, Humans ; Fusion Proteins, bcr-abl/antagonists & inhibitors ; Fusion Proteins, bcr-abl/genetics ; History, 20th Century ; History, 21st Century ; Clinical Trials, Phase III as Topic ; Imatinib Mesylate/administration & dosage ; Imatinib Mesylate/adverse effects ; Niacinamide/administration & dosage ; Niacinamide/adverse effects ; Niacinamide/analogs & derivatives ; Pyrazoles/administration & dosage ; Pyrazoles/adverse effects ; Randomized Controlled Trials as Topic ; Treatment Outcome

المؤلفون: Saugues S; Hématologie FBeirorlaongdiq, uFer,a nCcHe U Clermont-Ferrand, Clermont; Equipe d'Accueil EA7453 CHELTER, Université Clermont Auvergne, Clermont-Ferrand., Lambert C; Unité de Biostatistiques, DRCI, CHU Clermont-Ferrand, Clermont-Ferrand., Daguenet E; Hématologie, Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez., Roth-Guepin G; Hématologie Clinique, CHRU Brabois, Vandoeuvre-les-Nancy., Huguet F; Hématologie, Institut Universitaire du Cancer Toulouse Oncopole, CHU de Toulouse, Toulouse., Cony-Makhoul P; Hématologie, CH Annecy-Genevois, Pringy., Ansah HJ; Institut d'Hématologie de Basse Normandie, CHU, Caen., Escoffre-Barbe M; Hématologie, Hôpital de Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes., Turhan A; Inserm U935 - Service d'Hématologie, Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre., Rousselot P; Hématologie Clinique, Centre Hospitalier de Versailles and UMR1184, Le Chesnay., Tchirkov A; Unité de Biostatistiques, DRCI, CHU Clermont-Ferrand, Clermont-Ferrand, France; Cytogénétique Médicale, CHU Clermont-Ferrand, Clermont-Ferrand., Hamroun D; Direction de La Recherche Et de L'Innovation, CHRU de Montpellier, Montpellier., Hermet E; Hématologie Clinique Adulte, CHU Clermont-Ferrand, Clermont-Ferrand., Pereira B; Unité de Biostatistiques, DRCI, CHU Clermont-Ferrand, Clermont-Ferrand., Berger MG; Hématologie FBeirorlaongdiq, uFer,a nCcHe U Clermont-Ferrand, Clermont; Equipe d'Accueil EA7453 CHELTER, Université Clermont Auvergne, Clermont-Ferrand, France; Hématologie Clinique Adulte, CHU Clermont-Ferrand, Clermont-Ferrand. mberger@chuclermontferrand.Fr.

المصدر: Haematologica [Haematologica] 2024 Sep 01; Vol. 109 (9), pp. 2893-2907. Date of Electronic Publication: 2024 Sep 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/mortality , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/diagnosis , Protein Kinase Inhibitors*/therapeutic use , Remission Induction* , Neoplasm, Residual*/diagnosis, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/antagonists & inhibitors ; Prognosis ; Treatment Outcome ; Aged, 80 and over ; Young Adult ; Cohort Studies

المؤلفون: Kim SY; Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: ksuny55@gmail.com., Song IC; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea., Kim J; Department of Laboratory Medicine, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea., Kwon GC; Department of Laboratory Medicine, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.

المصدر: Annals of diagnostic pathology [Ann Diagn Pathol] 2024 Aug; Vol. 71, pp. 152317. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: W.B. Saunders Co Country of Publication: United States NLM ID: 9800503 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8198 (Electronic) Linking ISSN: 10929134 NLM ISO Abbreviation: Ann Diagn Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Colony-Stimulating Factor*/genetics , Mutation* , Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative*/genetics , Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative*/pathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Leukemia, Neutrophilic, Chronic/genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/pathology

المؤلفون: Chatain N; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany. nchatain@ukaachen.de.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany. nchatain@ukaachen.de., Baumeister J; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Szymanski de Toledo MA; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Wong DWL; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.; Institute of Pathology, RWTH Aachen University Clinic, Aachen, Germany., Gupta S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Pannen K; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Junge B; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany., Boor P; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.; Institute of Pathology, RWTH Aachen University Clinic, Aachen, Germany., Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany. skoschmieder@ukaachen.de.; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany. skoschmieder@ukaachen.de.

المصدر: Leukemia [Leukemia] 2024 Aug; Vol. 38 (8), pp. 1825-1830. Date of Electronic Publication: 2024 Jun 21.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Neoplastic Stem Cells*/drug effects , Neoplastic Stem Cells*/pathology , Neoplastic Stem Cells*/metabolism , Fusion Proteins, bcr-abl*/antagonists & inhibitors , Fusion Proteins, bcr-abl*/genetics , Blast Crisis*/pathology , Blast Crisis*/drug therapy, Humans ; Animals ; Mice ; Pyrazoles/pharmacology ; Pyrazoles/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-abl/metabolism ; Proto-Oncogene Proteins c-abl/antagonists & inhibitors ; Proto-Oncogene Proteins c-abl/genetics ; Niacinamide/analogs & derivatives

المؤلفون: Huang CY; Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan., Chung YH; Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan., Wu SY; Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan., Wang HY; Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan., Lin CY; Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan., Yang TJ; Institute of Chemistry, National Taiwan University, Taipei, Taiwan., Fang JM; Institute of Chemistry, National Taiwan University, Taipei, Taiwan., Hu CM; Genomics Research Center, Academia Sinica, Taipei, Taiwan., Chang ZF; Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. zfchang@ntu.edu.tw.; Center of Precision Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. zfchang@ntu.edu.tw.

المصدر: Communications biology [Commun Biol] 2024 Jul 10; Vol. 7 (1), pp. 843. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/metabolism , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics , Glutathione*/metabolism, Humans ; Animals ; Mice ; Protein Kinase Inhibitors/pharmacology ; Drug Resistance, Neoplasm/drug effects ; Cell Line, Tumor ; Fusion Proteins, bcr-abl/metabolism ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/antagonists & inhibitors

المؤلفون: Krumbholz M; Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Dolnik A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Berlin, Germany., Sträng E; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Berlin, Germany., Ghete T; Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany., Skambraks S; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Hutter S; MLL Munich Leukemia Laboratory, Munich, Germany., Simonis A; Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany., Stegelmann F; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Suttorp M; Medical Faculty, Pediatric Hematology and Oncology, Technical University, Dresden, Germany., Horn AHC; Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.; Erlangen National High Performance Computing Center (NHR@FAU), Friedrich-Alexander- Universität Erlangen-Nürnberg, 91058, Erlangen, Germany., Sticht H; Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow Klinikum, Berlin, Germany.; Corporate member of Freie Universität Berlin and Humboldt, partner site Berlin, Universitätsmedizin Berlin, Universität zu Berlin, German Cancer Consortium (DKTK), Berlin, Germany., Metzler M; Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Loschgestrasse 15, 91054, Erlangen, Germany. Markus.Metzler@uk-erlangen.de.; Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany. Markus.Metzler@uk-erlangen.de.; Bavarian Cancer Research Center (BZKF), Erlangen, Germany. Markus.Metzler@uk-erlangen.de.

المصدر: Molecular cancer [Mol Cancer] 2024 Sep 26; Vol. 23 (1), pp. 206. Date of Electronic Publication: 2024 Sep 26.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/pathology , Germ-Line Mutation* , Genetic Predisposition to Disease*, Humans ; Child ; Adolescent ; Male ; Female ; Child, Preschool ; Fusion Proteins, bcr-abl/genetics ; Adult ; Exome Sequencing ; Infant

المؤلفون: Nelson EA; Department of Haematology and Blood Transfusion, Obafemi Awolowo University, Teaching Hospitals Complex, Ile-Ife, Nigeria., Ahmed IO; Department of Haematology and Blood Transfusion, Obafemi Awolowo University, Teaching Hospitals Complex, Ile-Ife, Nigeria. ibrahimsew@yahoo.com., Bolarinwa RA; Department of Haematology and Blood Transfusion, Obafemi Awolowo University, Teaching Hospitals Complex, Ile-Ife, Nigeria.; Department of Haematology and Immunology, Obafemi Awolowo University, Ile-Ife, Nigeria., Adeagbo BA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria., Adegbola AJ; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria., Salawu L; Department of Haematology and Blood Transfusion, Obafemi Awolowo University, Teaching Hospitals Complex, Ile-Ife, Nigeria.; Department of Haematology and Immunology, Obafemi Awolowo University, Ile-Ife, Nigeria., Bolaji OO; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria., Durosinmi MA; Department of Haematology and Blood Transfusion, Obafemi Awolowo University, Teaching Hospitals Complex, Ile-Ife, Nigeria.; Department of Haematology and Immunology, Obafemi Awolowo University, Ile-Ife, Nigeria.

المصدر: BMC research notes [BMC Res Notes] 2024 Sep 03; Vol. 17 (1), pp. 245. Date of Electronic Publication: 2024 Sep 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500 (Electronic) Linking ISSN: 17560500 NLM ISO Abbreviation: BMC Res Notes Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Imatinib Mesylate*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Adult ; Retrospective Studies ; Nigeria ; Prognosis ; Treatment Outcome ; Aged ; Young Adult ; Antineoplastic Agents/therapeutic use ; Adolescent ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/antagonists & inhibitors ; Poverty

المؤلفون: Park SE, Lee JK, Kang HJ, Hong YJ, Oh AC, Kim H

المصدر: Clinical laboratory [Clin Lab] 2024 Sep 01; Vol. 70 (9).

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Clinical Laboratory Publications Country of Publication: Germany NLM ID: 9705611 Publication Model: Print Cited Medium: Internet ISSN: 1433-6510 (Print) Linking ISSN: 14336510 NLM ISO Abbreviation: Clin Lab Subsets: MEDLINE

مواضيع طبية MeSH: Translocation, Genetic* , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/diagnosis , Philadelphia Chromosome*, Humans ; Male ; Adult ; Clonal Evolution/genetics ; Fusion Proteins, bcr-abl/genetics ; Imatinib Mesylate/therapeutic use ; Pyrimidines/therapeutic use ; Chromosomes, Human, X/genetics ; Antineoplastic Agents/therapeutic use